erythromycin has been researched along with Pyloric Stenosis in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.52) | 18.7374 |
1990's | 1 (4.76) | 18.2507 |
2000's | 16 (76.19) | 29.6817 |
2010's | 2 (9.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broutet, N; Lincetto, O; Santesso, N; Schünemann, H; Wi, T; Zikic, A | 1 |
Hernández-Díaz, S; Lin, KJ; Louik, C; Mitchell, AA; Yau, WP | 1 |
Hayakawa, K; Hiraoka, M; Kobata, R; Mayumi, M; Shiima, Y; Tsukahara, H | 1 |
Herson, VC; Hussain, N | 1 |
Amsden, GW; Hauben, M | 1 |
Downs, SM; Kleiman, MB; Mahon, BE; Rosenman, MB | 1 |
Osterholm, MT | 1 |
Hoey, J | 1 |
García Martín, FJ; Milano Manso, G; Oliva Rodríguez-Pastor, S | 1 |
Kleiman, MB; Mahon, BE; Rosenman, MB | 1 |
Louik, C; Mitchell, AA; Werler, MM | 1 |
Sondheimer, JM | 1 |
Arbogast, P; Cooper, WO; Gautam, S; Griffin, MR; Hickson, GB; Ray, WA | 1 |
Cooper, WO; Griffin, MR; Ray, WA | 1 |
SanFilippo, A | 1 |
Stang, H | 1 |
2 review(s) available for erythromycin and Pyloric Stenosis
Article | Year |
---|---|
Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Bias; Chlamydia Infections; Chlamydia trachomatis; Conjunctivitis, Bacterial; Drug Administration Schedule; Erythromycin; Female; Gastrointestinal Diseases; Humans; Infant, Newborn; Male; Pyloric Stenosis; Risk Factors; Trimethoprim | 2018 |
The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Cohort Studies; Databases, Factual; Digestive System; Erythromycin; Female; Gastrointestinal Motility; Humans; Hypertrophy; Infant; Infant, Newborn; Male; Pyloric Stenosis; Retrospective Studies | 2002 |
19 other study(ies) available for erythromycin and Pyloric Stenosis
Article | Year |
---|---|
Safety of macrolides during pregnancy.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Female; Heart Defects, Congenital; Humans; Logistic Models; Macrolides; Pregnancy; Prenatal Exposure Delayed Effects; Pyloric Stenosis; Risk | 2013 |
Erythromycin in ELBW infants.
Topics: Chronic Disease; Erythromycin; Humans; Hypertrophy; Infant Welfare; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Lung Diseases; Male; Pyloric Stenosis; Treatment Failure | 2002 |
Erythromycin use during pregnancy in relation to pyloric stenosis.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Infant, Newborn; Pyloric Stenosis | 2002 |
Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Chlamydia Infections; Chlamydia trachomatis; Conjunctivitis, Bacterial; Decision Trees; Erythromycin; Female; Humans; Infant, Newborn; Pneumonia, Bacterial; Pregnancy; Pregnancy Complications, Infectious; Pyloric Stenosis | 2003 |
Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cluster Analysis; Cohort Studies; Erythromycin; Humans; Hypertrophy; Infant; Infant, Newborn; Infectious Disease Transmission, Professional-to-Patient; Pyloric Stenosis; Tennessee; Whooping Cough | 1999 |
From the Centers for Disease Control and Prevention. Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cluster Analysis; Cohort Studies; Erythromycin; Humans; Hypertrophy; Infant; Infant, Newborn; Infectious Disease Transmission, Professional-to-Patient; Pyloric Stenosis; Tennessee; Whooping Cough | 2000 |
Erythromycin use linked to pyloric stenosis.
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Hypertrophy; Infant, Newborn; Pyloric Stenosis | 2000 |
Erythromycin remains gold standard for treatment of pertussis in infants.
Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Infant; Male; Pyloric Stenosis; Risk Assessment; Treatment Outcome; Whooping Cough | 2000 |
Hypertrophic pyloric stenosis caused by erythromycin.
Topics: Anti-Bacterial Agents; Disease Outbreaks; Erythromycin; Female; Humans; Hypertrophy; Infant, Newborn; Kentucky; Male; Pyloric Stenosis; Whooping Cough | 2000 |
[Erythromycin and hypertrophic stenosis of the pylorus].
Topics: Anti-Bacterial Agents; Erythromycin; Humans; Hypertrophy; Infant, Newborn; Male; Pyloric Stenosis | 2001 |
Erythromycin-induced pyloric stenosis in infants.
Topics: Anti-Bacterial Agents; Breast Feeding; Cluster Analysis; Contraindications; Erythromycin; Female; Humans; Infant, Newborn; Pyloric Stenosis; Pylorus; United States; Whooping Cough | 2001 |
Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.
Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Hypertrophy; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Pyloric Stenosis; Retrospective Studies; Risk Factors | 2001 |
Erythromycin use during pregnancy in relation to pyloric stenosis.
Topics: Adult; Anti-Bacterial Agents; Case-Control Studies; Erythromycin; Female; Humans; Infant, Newborn; Odds Ratio; Pregnancy; Pregnancy Complications, Infectious; Pyloric Stenosis; Risk Assessment | 2002 |
A question that won't go away.
Topics: Anti-Bacterial Agents; Erythromycin; Female; Humans; Hypertrophy; Infant, Newborn; Maternal-Fetal Exchange; Pregnancy; Pyloric Stenosis; Retrospective Studies | 2002 |
More on erythromycin and pyloric stenosis.
Topics: Anti-Bacterial Agents; Cohort Studies; Erythromycin; Female; Humans; Infant; Male; Pyloric Stenosis; Retrospective Studies; Risk Factors | 2002 |
Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis.
Topics: Anti-Bacterial Agents; Cohort Studies; Erythromycin; Female; Gastrointestinal Agents; Humans; Hypertrophy; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infections; Male; Pyloric Stenosis; Pylorus; Retrospective Studies; Risk Factors; Tennessee; Time Factors | 2002 |
Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.
Topics: Adult; Anti-Bacterial Agents; Cohort Studies; Confidence Intervals; Erythromycin; Female; Gestational Age; Humans; Hypertrophy; Incidence; Infant, Newborn; Odds Ratio; Pregnancy; Prenatal Care; Probability; Pyloric Stenosis; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Sex Distribution; Tennessee | 2002 |
Infantile hypertrophic pyloric stenosis related to ingestion of erythromycine estolate: A report of five cases.
Topics: Erythromycin; Erythromycin Estolate; Female; Humans; Hypertrophy; Infant, Newborn; Male; Pyloric Stenosis; Retrospective Studies; Time Factors | 1976 |
Pyloric stenosis associated with erythromycin ingested through breastmilk.
Topics: Adult; Erythromycin; Female; Humans; Hypertrophy; Infant; Male; Milk, Human; Pyloric Stenosis; Retrospective Studies | 1986 |